Literature DB >> 18654840

Mus tales: a hands-on view.

Lawrence J T Young1.   

Abstract

The mouse model for breast cancer has developed into a most effective means of dissecting and understanding this devastating disease. The inbred transgenic mouse lends itself to biological, molecular, immunological, and genetic studies. The observation, dissection, transplantation, and subsequent amplification of precancerous mammary lesions and tumors give the scientist the means to readily study the tissues and design interventions and therapeutic drugs for the future eventual control of breast cancer. There are many inbred strains of mice, selected for specific characteristics. The mouse is easy to handle, breeds well, and does not require extensive facilities, funding, and handling such as monkeys, chimps, and other animal models. A huge advantage is the capability for the transplantation of tissues as well as gene manipulation, which make the transgenic mouse a major research resource. The mouse has served the scientific community well for over a century and will continue to do so in the quest for understanding breast cancer and other diseases.

Entities:  

Mesh:

Year:  2008        PMID: 18654840     DOI: 10.1007/s10911-008-9088-2

Source DB:  PubMed          Journal:  J Mammary Gland Biol Neoplasia        ISSN: 1083-3021            Impact factor:   2.673


  47 in total

1.  Persistent and atypical lobules in the human breast may be precancerous.

Authors:  S R Wellings; H M Jensen; M R DeVault
Journal:  Experientia       Date:  1976-11-15

2.  Some characteristics of the preneoplastic hyperplastic alveolar nodules of C3H/Crgl mice.

Authors:  K B DEOME; P B BLAIR; L J FAULKIN
Journal:  Acta Unio Int Contra Cancrum       Date:  1961

3.  Regulation of growth and spacing of gland elements in the mammary fat pad of the C3H mouse.

Authors:  L J FAULKIN; K B DEOME
Journal:  J Natl Cancer Inst       Date:  1960-04       Impact factor: 13.506

4.  The hormonal genesis of mammary cancer.

Authors:  O MUHLBOCK
Journal:  Adv Cancer Res       Date:  1956       Impact factor: 6.242

5.  Transgenic Polyoma middle-T mice model premalignant mammary disease.

Authors:  J E Maglione; D Moghanaki; L J Young; C K Manner; L G Ellies; S O Joseph; B Nicholson; R D Cardiff; C L MacLeod
Journal:  Cancer Res       Date:  2001-11-15       Impact factor: 12.701

6.  The histocompatability-2 locus and susceptibility to bittner virus borne by red blood cells in mice.

Authors:  S Nandi
Journal:  Proc Natl Acad Sci U S A       Date:  1967-08       Impact factor: 11.205

7.  Mammary tumors in feral mice lacking MuMTV DNA.

Authors:  M B Gardner; R W Malone; D W Morris; L J Young; R Strange; R D Cardiff; L J Faulkin; D J Mitchell
Journal:  J Exp Pathol       Date:  1985

Review 8.  Genetically engineered mouse models of mammary intraepithelial neoplasia.

Authors:  R D Cardiff; D Moghanaki; R A Jensen
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

9.  Hyperplastic and neoplastic changes in the mammary glands of feral mice free of endogenous mouse mammary tumor virus provirus.

Authors:  L J Faulkin; D J Mitchell; L J Young; D W Morris; R W Malone; R D Cardiff; M B Gardner
Journal:  J Natl Cancer Inst       Date:  1984-10       Impact factor: 13.506

10.  THE MILK-INFLUENCE OF BREAST TUMORS IN MICE.

Authors:  J J Bittner
Journal:  Science       Date:  1942-05-01       Impact factor: 47.728

View more
  2 in total

Review 1.  Mammary stem cell research in veterinary science: an update.

Authors:  Bizunesh M Borena; Leen Bussche; Christian Burvenich; Luc Duchateau; Gerlinde R Van de Walle
Journal:  Stem Cells Dev       Date:  2013-03-05       Impact factor: 3.272

Review 2.  A Comparative Study on the In Vitro Effects of the DNA Methyltransferase Inhibitor 5-Azacytidine (5-AzaC) in Breast/Mammary Cancer of Different Mammalian Species.

Authors:  Rebecca M Harman; Theresa M Curtis; David J Argyle; Scott A Coonrod; Gerlinde R Van de Walle
Journal:  J Mammary Gland Biol Neoplasia       Date:  2016-03-22       Impact factor: 2.673

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.